贝沙罗汀增强实验性脑出血后巨噬细胞噬红细胞作用并促进血肿清除
本研究在两种小鼠脑出血模型中探讨视黄醇X受体激动剂贝沙罗汀对巨噬细胞噬红细胞作用及神经行为恢复的治疗效果。体外实验显示贝沙罗汀增加巨噬细胞吞噬受体表达和噬红细胞作用,并减少TNF产生;体内实验表明贝沙罗汀治疗增强噬红细胞作用、减小血肿体积并改善神经功能恢复。结论认为贝沙罗汀通过增强血肿吞噬、调节巨噬细胞表型改善脑出血后恢复。
要点
- 贝沙罗汀在体外增强巨噬细胞噬红细胞作用并减少TNF产生。
- 在两种小鼠脑出血模型中,贝沙罗汀减小血肿体积并改善神经功能恢复。
- 贝沙罗汀可能通过调节巨噬细胞表型促进脑出血后恢复。
核心结论
- 贝沙罗汀通过增强血肿吞噬、调节巨噬细胞表型并改善功能恢复,对脑出血后恢复有益。
研究设计与样本
- 研究采用体外骨髓来源巨噬细胞与荧光标记红细胞实验,并在两种小鼠脑出血模型(自体血和胶原酶注射)中于脑出血后3小时开始贝沙罗汀治疗。
主要发现
- 体外实验中,贝沙罗汀增加巨噬细胞吞噬受体表达和噬红细胞作用,并减少巨噬细胞TNF产生。
- 体内实验中,贝沙罗汀治疗增强噬红细胞作用、减小血肿体积并最终改善两种脑出血模型后的神经功能恢复。
临床怎么用
- 贝沙罗汀可能作为促进脑出血后血肿清除和神经功能恢复的潜在治疗药物。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background and Purpose- Enhancement of erythrophagocytosis by macrophages in a timely manner can limit the toxic effects of erythrocyte metabolites and promote brain recovery after intracerebral hemorrhage (ICH). In the current study, we investigated the therapeutic effect of retinoid X receptor agonist, bexarotene, in facilitating erythrophagocytosis and neurobehavioral recovery in 2 mouse models of ICH. Methods- Bone marrow-derived macrophages and fluorescently labeled erythrocytes were used to study erythrophagocytosis in vitro with phenotypic changes quantified by gene expression. ICH was modeled in vivo using intrastriatal autologous blood and collagenase injection in mice with and without bexarotene treatment beginning 3 hours after ICH. In vivo phagocytosis, ability and hematoma clearance were evaluated by erythrophagocytosis assays, flow cytometry, and histological analysis. Neurological deficits and functional recovery were also quantified. Results- Bexarotene increased macrophage expression of phagocytosis receptors and erythrophagocytosis and reduced macrophage TNF (tumor necrosis factor) production in vitro. In vivo, bexarotene treatment enhanced erythrophagocytosis, reduced hematoma volume, and ultimately improved neurological recovery after ICH in 2 distinct models of ICH. Conclusions- Bexarotene administration is beneficial for recovery after ICH by enhancing hemorrhage phagocytosis, modulating macrophage phenotype, and improving functional recovery.
引用
- Chang CF, Massey J, Osherov A, et al. Bexarotene Enhances Macrophage Erythrophagocytosis and Hematoma Clearance in Experimental Intracerebral Hemorrhage. Stroke. 2019. PMID: 31826730. doi:10.1161/STROKEAHA.119.027037
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。